DaVita Inc - DVA STOCK NEWS

DaVita Inc. appoints new independent director, Dennis Pullin, to its Board of Directors, enhancing healthcare expertise.

The American Diabetes Association (ADA) and DaVita (DVA) expand collaboration to advance chronic disease prevention, focusing on diabetes and chronic kidney disease (CKD) during National Kidney Month. DaVita contributes $1.5 million to support ADA initiatives targeting at-risk individuals. Efforts include creating educational materials, piloting a registered dietitian program, and sponsoring State of Diabetes events.

DaVita Inc. (DVA) CFO and VP of Investor Relations to participate in fireside chat at Barclays Global Healthcare Conference 2024.

DaVita Inc (NYSE: DVA) expands its international operations in Latin America through strategic acquisitions, making it the largest dialysis services provider in the region. The $300M USD deal with Fresenius Medical Care involves four acquisitions, boosting DaVita's presence in Brazil, Colombia, Chile, and Ecuador.

DaVita Inc. (DVA) CFO and VP to participate in a fireside chat at TD Cowen's Health Care Conference 2024.

DaVita Inc. (DVA) reported strong financial and operating results for the quarter and year ended December 31, 2023, with consolidated revenues of $3.146 billion and $12.140 billion, operating income of $390 million and adjusted operating income of $415 million for the quarter, and $1,603 million and $1,734 million for the year, diluted earnings per share from continuing operations of $1.62 and adjusted diluted earnings per share of $1.87 for the quarter, and $7.42 and $8.47 for the year, operating cash flow of $485 million and free cash flow of $258 million for the quarter, and $2,059 million and $1,236 million for the year. DaVita also repurchased 2,903,832 shares of common stock at an average price of $97.82 per share. The company provided insights into U.S. dialysis metrics, revenue per treatment, patient care costs per treatment, and general and administrative expenses, highlighting the primary drivers of changes in these areas. Additionally, DaVita discussed key items impacting the quarter and year, such as integrated kidney care revenues, closure costs, severance costs, goodwill impairment, and share repurchases.

DaVita Inc. (NYSE: DVA) is set to hold its quarterly conference call to discuss fourth quarter results on February 13, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. The call will be webcast and can be accessed at the DaVita IR web page. Investors unable to listen to the conference call will be able to access a replay via the company's website at investors.davita.com.

DaVita Inc. (DVA) awards Western Governors University's (WGU) Michael O. Leavitt School of Health (LSH) a $1 million grant over the next three years to support more than 1,500 nursing students in the Start Early program, aimed at increasing nursing degree completion rates. The program addresses the critical nursing workforce shortage in the U.S. and will provide financial support, scholarships, and resources to nursing students facing barriers to education.

DaVita (DVA) successfully raised over $750,000 through its 2023 Move It With Purpose event, with a record-breaking participation of more than 6,400 movers logging nearly 400,000 total miles. Since 2007, DaVita has raised over $15 million for Bridge of Life, a nonprofit supporting chronic disease prevention and treatment globally.